12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga · 1d ago
Gainers
- Sensei Biotherapeutics (NASDAQ:SNSE) stock increased by 23.2% to $11.65 during Thursday's after-market session. The company's market cap stands at $11.8 million.
- Alphatec Holdings (NASDAQ:ATEC) stock moved upwards by 21.24% to $19.8. The company's market cap stands at $2.4 billion. The company's, Q3 earnings came out today.
- Harvard Bioscience (NASDAQ:HBIO) shares increased by 18.68% to $0.75. The market value of their outstanding shares is at $19.8 million.
- iRhythm Technologies (NASDAQ:IRTC) stock increased by 16.22% to $214.0. The market value of their outstanding shares is at $5.9 billion. As per the press release, Q3 earnings came out today.
- Ardelyx (NASDAQ:ARDX) shares increased by 13.02% to $5.64. The market value of their outstanding shares is at $1.1 billion. The company's, Q3 earnings came out today.
- Travere Therapeutics (NASDAQ:TVTX) shares increased by 11.29% to $33.0. The market value of their outstanding shares is at $2.6 billion. The company's, Q3 earnings came out today.
Losers
- Intensity Therapeutics (NASDAQ:INTS) shares declined by 29.3% to $0.93 during Thursday's after-market session. The company's market cap stands at $13.0 million.
- Jin Medical International (NASDAQ:ZJYL) stock fell 19.66% to $0.24. The market value of their outstanding shares is at $47.1 million.
- Corbus Pharmaceuticals (NASDAQ:CRBP) stock fell 17.7% to $13.53. The market value of their outstanding shares is at $206.6 million.
- MSP Recovery (NASDAQ:MSPR) stock fell 12.93% to $0.27.
- DexCom (NASDAQ:DXCM) shares fell 12.69% to $59.55. The market value of their outstanding shares is at $26.7 billion. As per the news, the Q3 earnings report came out today.
- Azitra (AMEX:AZTR) stock declined by 9.31% to $0.54. The market value of their outstanding shares is at $1.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.